Stem Cell Therapy in Tennessee
The Tennessee General Assembly advanced HB 413 and SB 152 during the 2025 legislative session, a pair of companion bills that would authorize patients with severe chronic diseases or terminal illnesses to access investigational stem cell treatments not yet approved by the U.S. Food and Drug Administration (FDA). The Senate Health and Welfare Committee passed […]